Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patient Insights on Online Symptom Assessment Tools Utilizing Artificial Intelligence for Diagnosing Systemic Lupus Erythematosus

  • By

  • Olivia A. Stein

  • Jennifer L. F. Lee

  • Evelyne Vinet

  • Arielle Mendel

  • Christian A. Pineau

  • Fares Kalache

  • Louis-Pierre Grenier

  • Sasha Bernatsky

  • May 28, 2026

Share

  • 1

    Timely diagnosis of systemic lupus erythematosus (SLE) is challenging due to heterogeneous symptoms and inadequate awareness among healthcare providers.

  • 2

    Patients with SLE often experience significant delays in diagnosis, averaging one to two years, which can lead to severe disease progression.

  • 3

    The study evaluates AI symptom checkers in the context of SLE, highlighting their potential usefulness and limitations in real-world diagnostic journeys.

  • 4

    Structural issues in healthcare may limit the effectiveness of AI-based symptom assessment tools for complex conditions like SLE.

  • 5

    The research aims to capture patient perspectives on AI tools, focusing on their benefits, limitations, and concerns regarding diagnostic experiences.

Original Source(s)

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

  • by Olivia A. Stein, Jennifer L. F. Lee, Evelyne Vinet, Arielle Mendel, Christian A. Pineau, Fares Kalache, Louis-Pierre Grenier, Sasha Bernatsky

  • May 28, 2026

Related Content

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.